Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

August 6, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Nano catalytic tumour therapy by single-atom catalysts

Neurodegeneration can now be cured by improving Autophagy pathways

Life Sciences Project Research Associate Job With Rs. 47,000 pm at RCB

Nano catalytic tumour therapy by single-atom catalysts
  • BiotechToday
  • World

Nano catalytic tumour therapy by single-atom catalysts

bioxone January 26, 2021January 26, 2021

Rohit Bhattacharjee, Amity University, Kolkata

Recently, single‐atom catalysts (SACs) are receiving increasing attention in varied chemical process fields, and meantime, rising nano catalytic drugs provide a unique tumor therapy modality while not victimizing harmful chemo drugs. The distinct properties of SACs, like exactly situated metal centers, identical coordination setting, tailorable composition and structure, and versatile practicality, build them promising candidates for chemical process tumor medical care. 

There are some foremost recent advances in nano catalytic tumor medical care by using various forms of SACs, particularly their outstanding achievements in different categories of nano catalytic tumor modes, like chemodynamic therapy, photodynamic therapy, sonodynamic therapy, and parallel chemical process therapy. Thermodynamic therapies involve chemical reaction processes, photodynamic therapies involve light energy to accelerate chemical reaction processes, sonocatalytic therapies involve ultrasound in chemical reactions, and parallel chemical process therapies involve two or more chemical reactions occurring simultaneously. These are reviewed by minute observation in the construction of catalytic platforms of nanoparticles and their mechanism. Thereafter a focused outline and outlook is provided finally to stipulate the views and also the remaining challenges for the longer term style and engineering of SACs for tumor therapy.

Also read: Neurodegeneration can now be cured by improving Autophagy pathways

Source:- https://onlinelibrary.wiley.com/doi/10.1002/smll.202004467

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged chemodynamic therapy nanocatalytic drugs parallel chemical process therapy photodynamic therapy single-atom catalysts (SACs) sonodynamic therapy tumour therapy

One thought on “Nano catalytic tumour therapy by single-atom catalysts”

  1. Pingback: Direct Air Capture: Can wartime-level investment in novel tech slow down Global Warming? - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship
  • Signaling Pathway

Life Sciences Project Research Associate Job With Rs. 47,000 pm at RCB

bioxone January 26, 2021

-Shristi Sharma, Team bioXone Life Sciences Project Research Associate Job With Rs. 47,000 pm at RCB. RCB is hiring PhD life science candidates. Eligible candidates can apply online for the Project Research Associate vacancy. Regional Centre for Biotechnology job vacancy for PhD details below: RCB Vacancy Details Advt. No. 02/Project/2021/HR Name of Job: Project Research […]

Related Post

  • BiotechToday
  • FEATURED
  • India
  • Latest

COVID: One in every four persons have Covid-19 Antibodies in Kolkata

bioxone September 12, 2020September 12, 2020

-Sayak Biswas, Amity University, Kolkata During a time when the coronavirus is spreading like a wildfire across the whole world, a private laboratory in West Bengal has claimed that one in every four persons have Covid-19 Antibodies in Kolkata. This news has come as a relief to a State which has already seen over 1.87 […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • FEATURED
  • Latest
  • World

CAN LUNG CANCER MAKE YOU TEST POSITIVE FOR COVID-19?

bioxone September 10, 2020September 10, 2020

–Biswadeep Sen, Amity University Kolkata Lung Cancer is one of the most malignant tumors, making patients more susceptible to infections than normal individuals. Lung Cancer patients are susceptible to SARS-CoV-2 infection at a significantly higher rate than healthy individuals. Angiotensin-converting enzyme 2, acting as the COVID receptor, and the Transmembrane protease serine 2 acting as […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

New device ensures to detect Antibiotic Resistant Bacteria within 5 hours

bioxone December 9, 2020December 9, 2020

Devyani Goswami, Amity University Kolkata Another threat to human civilization apart from the current COVID-19 situation is the growing risk of antibiotic-resistant bacteria due to overuse and un-prescribed consumption of antibiotics. An annual death of more than 2 million all across the globe made researchers find out a solution on how to control this risk. […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy